MAGISTRELLI, ELEONORA
MAGISTRELLI, ELEONORA
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
2017 Calza L, Colangeli V, Magistrelli E, Bussini L, Conti M, Ramazzotti E, Mancini R, Viale P.
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy
2017 Calza, Leonardo; Colangeli, Vincenzo; Magistrelli, Eleonora; Contadini, Ilaria; Bon, Isabella; Re, Maria Carla; Conti, Matteo; Mancini, Rita; Viale, Pierluigi
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors
2016 Calza, Leonardo; Danese, Ilaria; Magistrelli, Eleonora; Colangeli, Vincenzo; Manfredi, Roberto; Bon, Isabella; Re, Maria Carla; Conti, Matteo; Viale, Pierluigi
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy
2016 Calza, Leonardo; Colangeli, Vincenzo; Magistrelli, Eleonora; Manfredi, Roberto; Bon, Isabella; Re, MARIA CARLA; Viale, Pierluigi
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.
2015 Calza, L; Danese, I; Colangeli, V; Manfredi, R; Magistrelli, E; Verucchi, G; Conti, M; Motta, R; Viale, P
Abdominal neoplasia with sarcomatoid features as the presenting illness of a patient with a newly diagnosed HIV infection and no AIDS-related disorders. Case report, clinical and diagnostic features, and literature discussion
2014 Manfredi R.; Sabbatani S.; Magistrelli E.; Tardio M.L.
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk.
2013 Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P.